Canagliflozin: Effects in overweight and obese subjects without diabetes mellitus

OBJECTIVE: To evaluate the effects of canagliflozin, a sodium glucose co-transporter 2 inhibitor, on body weight in overweight and obese subjects (body mass index [BMI] ≥27 and <50 kg/m(2)). METHODS: This 12-week, Phase 2b, randomized, double-blind study enrolled 376 subjects without diabetes mel...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Obesity (Silver Spring)
Asıl Yazarlar: Bays, Harold E, Weinstein, Richard, Law, Gordon, Canovatchel, William
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BlackWell Publishing Ltd 2014
Konular:
Original Articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4285787/
https://ncbi.nlm.nih.gov/pubmed/24227660
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/oby.20663
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller